Oridonin overcomes the gemcitabine resistant PANC-1/Gem cells by regulating GST pi and LRP/1 ERK/JNK signalling
Bili Wang,1,* Can Shen,1,2,* Yang Li,1 Ting Zhang,1 Hui Huang,1 Jun Ren,1 Zhengjun Hu,3 Jian Xu,1 Bin Xu41Department of Clinical Laboratory, Medical Technology College, Zhejiang Chinese Medical University, Hangzhou 310053, People’s Republic of China; 2Department of Clinical Labora...
Main Authors: | Wang B, Shen C, Li Y, Zhang T, Huang H, Ren J, Hu Z, Xu J, Xu B |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2019-07-01
|
Series: | OncoTargets and Therapy |
Subjects: | |
Online Access: | https://www.dovepress.com/oridonin-overcomes-the-gemcitabine-resistant-panc-1gem-cells-by-regula-peer-reviewed-article-OTT |
Similar Items
-
Antiangiogenic effects of oridonin
by: Lili Tian, et al.
Published: (2017-04-01) -
Design and synthesis of novel oridonin analogues as potent anticancer agents
by: Qing-Kun Shen, et al.
Published: (2018-01-01) -
Oridonin and its derivatives for cancer treatment and overcoming therapeutic resistance
by: Xi Liu, et al.
Published: (2021-07-01) -
Protective effects of oridonin on the sepsis in mice
by: Yan-Jun Zhao, et al.
Published: (2016-09-01) -
Oridonin Induces Apoptosis of Laryngeal Carcinoma via Endoplasmic Reticulum Stress
by: Kou B, et al.
Published: (2020-09-01)